BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8275731)

  • 1. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
    Suter PM; Domenighetti G; Schaller MD; Laverrière MC; Ritz R; Perret C
    Chest; 1994 Jan; 105(1):190-4. PubMed ID: 8275731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.
    Domenighetti G; Suter PM; Schaller MD; Ritz R; Perret C
    J Crit Care; 1997 Dec; 12(4):177-82. PubMed ID: 9459113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 67gallium-transferrin pulmonary leak index in patients at risk for the acute respiratory distress syndrome.
    Groeneveld AB; Raijmakers PG
    Crit Care Med; 1998 Apr; 26(4):685-91. PubMed ID: 9559605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
    Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
    Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
    Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
    Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
    Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
    Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group.
    Bernard GR; Wheeler AP; Arons MM; Morris PE; Paz HL; Russell JA; Wright PE
    Chest; 1997 Jul; 112(1):164-72. PubMed ID: 9228372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
    Dellinger RP; Zimmerman JL; Taylor RW; Straube RC; Hauser DL; Criner GJ; Davis K; Hyers TM; Papadakos P
    Crit Care Med; 1998 Jan; 26(1):15-23. PubMed ID: 9428538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.
    Meduri GU; Headley AS; Golden E; Carson SJ; Umberger RA; Kelso T; Tolley EA
    JAMA; 1998 Jul; 280(2):159-65. PubMed ID: 9669790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial.
    Abraham E; Park YC; Covington P; Conrad SA; Schwartz M
    Crit Care Med; 1996 Jan; 24(1):10-5. PubMed ID: 8565513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An analysis of prognostic factors in patients suffering from acute lung injury/acute respiratory distress syndrome complicated with Yangming Fushi syndrome: a report of 206 cases from multiple centers].
    Yan L; Fu Q; Du C; Yu Y; Li J; Liu Q; Xue C; Qi Q; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jul; 27(7):548-51. PubMed ID: 26138414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.
    Krenn K; Lucas R; Croizé A; Boehme S; Klein KU; Hermann R; Markstaller K; Ullrich R
    Crit Care; 2017 Jul; 21(1):194. PubMed ID: 28750677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
    Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.
    Drago BB; Kimura D; Rovnaghi CR; Schwingshackl A; Rayburn M; Meduri GU; Anand KJ
    Pediatr Crit Care Med; 2015 Mar; 16(3):e74-81. PubMed ID: 25634565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study.
    Jepsen S; Herlevsen P; Knudsen P; Bud MI; Klausen NO
    Crit Care Med; 1992 Jul; 20(7):918-23. PubMed ID: 1617983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.
    Vincent JL; Brase R; Santman F; Suter PM; McLuckie A; Dhainaut JF; Park Y; Karmel J
    Intensive Care Med; 2001 Oct; 27(10):1578-83. PubMed ID: 11685297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis.
    Monchi M; Bellenfant F; Cariou A; Joly LM; Thebert D; Laurent I; Dhainaut JF; Brunet F
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1076-81. PubMed ID: 9769263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of enteral nutrition initiation timing on curative effect and prognosis of acute respiratory distress syndrome patients with mechanical ventilation].
    Guo Y; Cheng J; Li Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jun; 30(6):573-577. PubMed ID: 30009734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.